4.4 Review

Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference

Journal

PEDIATRIC NEUROLOGY
Volume 60, Issue -, Pages 1-12

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.pediatrneurol.2016.03.015

Keywords

-

Funding

  1. NIH [U01 NS082320, 1R01 NS078289, R35-CA197459, P01-CA120964]
  2. Developmental Synaptopathies Consortium, NCATS Rare Diseases Clinical Research Network (RDCRN) [U54NS092090]
  3. TSC
  4. LAM Research
  5. Amgen
  6. LAM Foundation
  7. Rare Lung Diseases Consortium, Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), NCATS [U54HL127672]
  8. Novartis
  9. National Institute of Neurological Disorders and Stroke (NINDS)
  10. Tuberous Sclerosis Alliance
  11. initiative of the Office of Rare Diseases Research (ORDR), NCATS

Ask authors/readers for more resources

On March 10 to March 12, 2015, the National Institute of Neurological Disorders and Stroke and the Tuberous Sclerosis Alliance sponsored a workshop in Bethesda, Maryland, to assess progress and new opportunities for research in tuberous sclerosis complex with the goal of updating the 2003 Research Plan for Tuberous Sclerosis (http://www.ninds.nih.goviabout_ninds/plansitscler_research_plan.htm). In addition to the National Institute of Neurological Disorders and Stroke and Tuberous Sclerosis Alliance, participants in the strategic planning effort and workshop included representatives from six other Institutes of the National Institutes of Health, the Department of Defense Tuberous Sclerosis Complex Research Program, and a broad cross-section of basic scientists and clinicians with expertise in tuberous sclerosis complex along with representatives from the pharmaceutical industry. Here we summarize the outcomes from the extensive premeeting deliberations and final workshop recommendations, including (1) progress in the field since publication of the initial 2003 research plan for tuberous sclerosis complex, (2) the key gaps, needs, and challenges that hinder progress in tuberous sclerosis complex research, and (3) a new set of research priorities along with specific recommendations for addressing the major challenges in each priority area. The new research plan is organized around both short-term and long-term goals with the expectation that progress toward specific objectives can be achieved within a five to ten year time frame. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available